Wide range of investigations are often performed to identify a molecular cause underlying congenital cataracts; these include TORCH screening; karyotyping; urinalysis for reducing agents and organic amino acids; and measurement of plasma galactokinase levels and basic blood tests, such as full-blood count and liver function tests [42]. This evidence concerns the gene GALK1 and Developmental cataract.